Close

TCRR and ADAP Related Headlines

Go Back

Jun 1, 2023 03:29PM Adaptimmune Announces Completion of Strategic Combination with TCR2 Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company

TCRR and ADAP Related Press Releases

Go Back

Jun 1, 2023 03:29PM Adaptimmune Announces Completion of Strategic Combination with TCR2 Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company

TCRR and ADAP Related SEC Filings

Go Back